Dublin, Sept. 13, 2019 (GLOBE NEWSWIRE) -- The "Neuroendovascular Coil Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.
The global neuroendovascular coil market is expected to grow at a CAGR of around 7% during 2019-2024.
This latest report provides a deep insight into the global neuroendovascular coil market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, & value chain analysis.
Several advances have been made in the neuroendovascular coil technology in terms of shape, length and bioactivity. Besides this, significant progress has been made in intracranial stents to improve their deployment and delivery. Surgeons have started integrating intracranial stents with the coil technology to treat aneurysms and reduce issues related to recurrence.
Moreover, endovascular coiling is being considered a better surgical technique than clipping regarding postoperative complications, favorable outcomes and rehabilitation.
Other than this, various market players are investing in the introduction of technologically advanced products. For instance, in 2018, Cerenovus, a division of the Johnson & Johnson Medical Devices Companies, launched the Galaxy G3 Mini embolic coil which is designed to have an irregular shape to enable the device to fill open spaces in cerebral aneurysms.
Key Topics Covered
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Neuroendovascular Coil Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Product Type
5.4 Market Breakup by Indication
5.5 Market Breakup by Application
5.6 Market Breakup by End User
5.7 Market Breakup by Region
5.8 Market Forecast
6 Market Breakup by Product Type
6.1 Guglielmi Detachable Coils (GDCs)
6.2 Matrix Coils
7 Market Breakup by Indication
7.1 Ruptured Aneurysm
7.2 Unruptured Aneurysm
8 Market Breakup by Application
8.1 Tumor Surgery
8.2 Medical Teaching
8.3 Others
9 Market Breakup by End User
9.1 Hospitals
9.2 Ambulatory Surgical Centers (ASCs)
9.3 Stroke Centers
9.4 Others
10 Market Breakup by Region
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Medtronic
15.3.2 Stryker Corporation
15.3.3 DePuy Synthes
15.3.4 Penumbra
15.3.5 Johnson & Johnson Services Inc.
15.3.6 Terumo Corporation
15.3.7 Cardinal Health
15.3.8 Boston Scientific Corporation
15.3.9 Cook Medical Incorporated
15.3.10 Balt Extrusion
15.3.11 EndoShape
For more information about this report visit https://www.researchandmarkets.com/r/sojdau
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.